CRF2 RECEPTOR AGONISTS AND THEIR USE IN THERAPY

The present disclosure provides compounds which are peptides comprising the amino acid sequence of the formula (I) disclosed herein or pharmaceutically acceptable salts thereof. The compounds act as agonists of the corticotropin-releasing factor receptor 2 (CRF2) and are useful in therapy, especiall...

Full description

Saved in:
Bibliographic Details
Main Authors ROVERSI, Daniela, LUCATS, Laurence, ILLIANO, Stephane, TRIPEPI, Martina, OZOUX, Marie-Laure, BIANCHI, Elisabetta, LEDEIN, Laetitia, EVERS, Andreas, BEAUVERGER, Philippe, JANIAK, Philip, ELVERT, Ralf, HALLAND, Nis, LI, Ziyu
Format Patent
LanguageEnglish
French
German
Published 25.09.2024
Subjects
CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
Online AccessGet full text

Cover

More Information
Summary:The present disclosure provides compounds which are peptides comprising the amino acid sequence of the formula (I) disclosed herein or pharmaceutically acceptable salts thereof. The compounds act as agonists of the corticotropin-releasing factor receptor 2 (CRF2) and are useful in therapy, especially in the treatment or prevention of cardiovascular diseases, obesity and diabetes.
Bibliography:Application Number: EP20240179173